SLIDESHOW

How brokerages are playing Infosys, Tata Motors & Dr Reddys

Mon, Jul 15, 2013 at 09:08

| Source: Moneycontrol.com
Share   .   Email   .   Print      

Dr Reddy’s

Brokerage: Citi

Rating: Buy

Target: Rs 2,125

Rationale: The approval for Dacogen is positive given the uncertainty over FDA approval timelines & the impact that it can have on street estimates for Dr Reddy's.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.